Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.4
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]        
Net revenue $ 6,469,000 $ 3,615,000 $ 10,968,000 $ 5,534,000
Cost of sales 4,980,000 3,289,000 8,606,000 5,091,000
Gross profit 1,489,000 326,000 2,362,000 443,000
Operating expenses:        
Selling and administrative expenses 3,135,000 2,229,000 6,055,000 4,492,000
Research and development 1,594,000 1,021,000 3,101,000 2,361,000
Total operating expenses 4,729,000 3,250,000 9,156,000 6,853,000
Operating loss (3,240,000) (2,924,000) (6,794,000) (6,410,000)
Interest expense (124,000) (383,000) (554,000) (711,000)
Net loss $ (3,364,000) $ (3,307,000) $ (7,348,000) $ (7,121,000)
Net loss per share - basic and diluted $ (0.29) $ (0.65) $ (0.69) $ (1.39)
Weighted average number of common shares outstanding - basic and diluted 11,633,793 5,106,781 10,647,181 5,105,061